David Fletcher

Cooley advised Everbridge, a global leader in critical event management and national public warning solutions, on its definitive agreement to be acquired by Thoma Bravo in an all-cash transaction valuing Everbridge at approximately $1.8 billion.

Cooley advised RayzeBio, a clinical-stage radiopharmaceutical therapeutics (RPT) company with an innovation-leading position in actinium-based RPTs and a pipeline of potentially first-in-class and best-in-class drug development programs, on its definitive agreement to be acquired by Bristol Myers Squibb.

Cooley advised LI-COR Environmental, a Battery Ventures portfolio company leading in greenhouse gas measurement technology, on its acquisition of Apollo SciTech’s assets.

Cooley advised Fontainebleau Aviation, a part of Fontainebleau Development’s luxury services division, on its partnership with Skyservice Business Aviation.

Cooley advised General Catalyst Partners, a venture capital firm providing early-stage and growth equity investments, as the lead investor in Helsing’s 209 million euro Series B financing.